THE USE OF CLONAZEPAM AS AN ANTICONVULSANT—CLINICAL EVALUATION
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Twenty-seven patients with various types of refractory epileptiform seizures were included in an open trial of a new anticonvulsant clonazepam. The main benefit was derived by the parenteral use of clonazepam in the treatment of various forms of status epilepticus, where it was very effective. Orally, clonazepam was most beneficial in patients with refractory petit-mal seizures, although a common side effect of behaviour disorder may limit its usefulness and its employment as an adjuvant at lower doses to current anticonvulsant regimes is currently being explored. Photomyoclonic epilepsy also responds extremely well to clonazepam. However, with other forms of epileptiform seizures, orally administered clonazepam offers few advantages over existing medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GASTAUT, H., ROGER, J., SOULAYROL, R., TASSINARI, C. A., RÉGIS, H., DRAVET, C., BERNARD, R., PINSARD, N., & SAINT‐JEAN, M. (1966) · Epilepsia · doi:10.1111/j.1528-1167.1966.tb06263.x · Cited by 431
Cited by
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Kienitz, R., Kay, L., Beuchat, I., Gelhard, S., von Brauchitsch, S., Mann, C., Lucaciu, A., Schäfer, J.-H., Siebenbrodt, K., Zöllner, J.-P., et al. (2022) · CNS Drugs · doi:10.1007/s40263-022-00940-2 · Cited by 139
Pinder (1976) · doi:10.2165/00003495-197612050-00001 · Cited by 111
Metadata
- Authors
- BLADIN, P. F.
- Venue
- Medical Journal of Australia
- Publisher
- AMPCo
- Published
- 1973-04
- Volume
- 1
- Issue
- 14
- Pages
- 683-688
- ISSN
- 0025-729X (ISSN-L)
- 1326-5377
- OpenAlex
- W2975111995
- Cited by
- 38
- References
- 1
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: THE USE OF CLONAZEPAM AS AN ANTICONVULSANT—CLINICAL EVALUATION. https://app.cochat.ai/papers/10.5694/j.1326-5377.1973.tb110623.x
- The paper
- BLADIN, P. F. (1973). THE USE OF CLONAZEPAM AS AN ANTICONVULSANT—CLINICAL EVALUATION. Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.1973.tb110623.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.